✦ LIBER ✦

953 SIPULEUCEL-T IN AFRICAN AMERICANS: A SUBGROUP ANALYSIS OF THREE PHASE 3 TRIALS OF SIPULEUCEL-T IN METASTATIC CASTRATE RESISTANT PROSTATE CANCER

✍ Scribed by McLeod, David G.; Quinn, David I.; Cullen, Jennifer; Whitmore, James B.

Book ID: 118484702
Publisher: Lippincott Williams and Wilkins
Year: 2012
Tongue: English
Weight: 47 KB
Volume: 187
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2012.02.1051

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sipuleucel-T immune parameters correlate

Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer

✍ Nadeem A. Sheikh, Daniel Petrylak, Philip W. Kantoff, Corazon dela Rosa, Frances 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 561 KB

The Role of Sipuleucel-T in Therapy for

The Role of Sipuleucel-T in Therapy for Castration-Resistant Prostate Cancer: A Critical Analysis of the Literature

✍ Guru Sonpavde; Giuseppe Di Lorenzo; Celestia S. Higano; Philip W. Kantoff; Ravi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 742 KB

Integrated data from 2 randomized, doubl

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

✍ Celestia S. Higano; Paul F. Schellhammer; Eric J. Small; Patrick A. Burch; John 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB

## Abstract ## BACKGROUND: Sipuleucel‐T is an investigational active cellular immunotherapy product designed to stimulate an immune response against prostate cancer. The safety and efficacy of sipuleucel‐T was evaluated in 2 identically designed, randomized, double‐blind, placebo‐controlled trials

Re: Overall Survival Analysis of a Phase

Re: Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

✍ David S. Finley; Frederic Pouliot; Allan Pantuck 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Re: Overall Survival Analysis of a Phase

Re: Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

✍ Ellen A.M. Schenk 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 438 KB

Final safety and efficacy analysis of th

Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-blind, placebo-controlled, randomized Phase II trial

✍ Nicholas D. James; Armelle Caty; Heather Payne; Michael Borre; Bernard A. Zonnen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB